APA (7th ed.) Citation

A, S., M, A., ME, C., C, D., E, v. C., A, W., . . . N, A. (2022). Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein. Vaccines, 10(4), . https://doi.org/10.3390/vaccines10040504

Chicago Style (17th ed.) Citation

A, Sengupta, et al. "Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response Against SARS-CoV-2 S1 Spike and Nucleocapsid Protein." Vaccines 10, no. 4 (2022). https://doi.org/10.3390/vaccines10040504.

MLA (9th ed.) Citation

A, Sengupta, et al. "Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response Against SARS-CoV-2 S1 Spike and Nucleocapsid Protein." Vaccines, vol. 10, no. 4, 2022, https://doi.org/10.3390/vaccines10040504.